Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).
CHENNAI: After a nine-year-old boy from Thirvur in Tiruvallur district died due to Guillain-Barre Syndrome (GBS) — a rare ...
The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle ...
A recent study published in the journal eLife has revealed significant links between blood types and the risk of developing ...
Nathan Bill’s holds ‘Supporting Samantha’ fundraiser for bartender with autoimmune diseases “This look is all about American ...
The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...
The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...
Most vegetables are good for your health and help prevent inflammation. However, some vegetables, like nightshades, can ...
Public health expert Emily Abel discusses with STAT the challenges to finding truly gluten-free foods, the topic of her new ...
Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells in the pancreas, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback